CN106750705A - The method of the consumption sub-light sub- optical wave physical therapy material of ripple composite preparation amount - Google Patents
The method of the consumption sub-light sub- optical wave physical therapy material of ripple composite preparation amount Download PDFInfo
- Publication number
- CN106750705A CN106750705A CN201710026590.9A CN201710026590A CN106750705A CN 106750705 A CN106750705 A CN 106750705A CN 201710026590 A CN201710026590 A CN 201710026590A CN 106750705 A CN106750705 A CN 106750705A
- Authority
- CN
- China
- Prior art keywords
- physical therapy
- optical wave
- sub
- wave physical
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000463 material Substances 0.000 title claims abstract description 66
- 238000000554 physical therapy Methods 0.000 title claims abstract description 44
- 230000003287 optical effect Effects 0.000 title claims abstract description 39
- 238000000034 method Methods 0.000 title claims abstract description 21
- 239000002131 composite material Substances 0.000 title claims abstract description 19
- 239000000203 mixture Substances 0.000 claims abstract description 24
- 239000004033 plastic Substances 0.000 claims abstract description 23
- 238000002347 injection Methods 0.000 claims abstract description 20
- 239000007924 injection Substances 0.000 claims abstract description 20
- 239000003292 glue Substances 0.000 claims abstract description 12
- 239000012467 final product Substances 0.000 claims abstract description 9
- 238000007711 solidification Methods 0.000 claims abstract description 9
- 230000008023 solidification Effects 0.000 claims abstract description 9
- 238000005469 granulation Methods 0.000 claims abstract description 4
- 230000003179 granulation Effects 0.000 claims abstract description 4
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 claims description 32
- AKEJUJNQAAGONA-UHFFFAOYSA-N sulfur trioxide Chemical compound O=S(=O)=O AKEJUJNQAAGONA-UHFFFAOYSA-N 0.000 claims description 28
- SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims description 26
- RUDFQVOCFDJEEF-UHFFFAOYSA-N yttrium(III) oxide Inorganic materials [O-2].[O-2].[O-2].[Y+3].[Y+3] RUDFQVOCFDJEEF-UHFFFAOYSA-N 0.000 claims description 17
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 13
- JKWMSGQKBLHBQQ-UHFFFAOYSA-N diboron trioxide Chemical compound O=BOB=O JKWMSGQKBLHBQQ-UHFFFAOYSA-N 0.000 claims description 11
- 230000003647 oxidation Effects 0.000 claims description 11
- 238000007254 oxidation reaction Methods 0.000 claims description 11
- DQMUQFUTDWISTM-UHFFFAOYSA-N O.[O-2].[Fe+2].[Fe+2].[O-2] Chemical compound O.[O-2].[Fe+2].[Fe+2].[O-2] DQMUQFUTDWISTM-UHFFFAOYSA-N 0.000 claims description 9
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 claims description 9
- 229910052726 zirconium Inorganic materials 0.000 claims description 9
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 8
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 8
- 239000004411 aluminium Substances 0.000 claims description 8
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 8
- 229910052782 aluminium Inorganic materials 0.000 claims description 8
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 8
- 229910052593 corundum Inorganic materials 0.000 claims description 8
- 229940056319 ferrosoferric oxide Drugs 0.000 claims description 8
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims description 8
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 claims description 8
- 229910001950 potassium oxide Inorganic materials 0.000 claims description 8
- ZCUFMDLYAMJYST-UHFFFAOYSA-N thorium dioxide Chemical compound O=[Th]=O ZCUFMDLYAMJYST-UHFFFAOYSA-N 0.000 claims description 8
- 229910001845 yogo sapphire Inorganic materials 0.000 claims description 8
- 229920001971 elastomer Polymers 0.000 claims description 5
- 239000005060 rubber Substances 0.000 claims description 5
- 229920001935 styrene-ethylene-butadiene-styrene Polymers 0.000 claims description 4
- 241000790917 Dioxys <bee> Species 0.000 claims 1
- 229910003978 SiClx Inorganic materials 0.000 claims 1
- 229910052681 coesite Inorganic materials 0.000 claims 1
- 229910052906 cristobalite Inorganic materials 0.000 claims 1
- 229910052710 silicon Inorganic materials 0.000 claims 1
- 239000010703 silicon Substances 0.000 claims 1
- 239000000377 silicon dioxide Substances 0.000 claims 1
- 229910052682 stishovite Inorganic materials 0.000 claims 1
- 229910052905 tridymite Inorganic materials 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 10
- 239000000693 micelle Substances 0.000 abstract description 7
- 239000008280 blood Substances 0.000 abstract description 6
- 210000004369 blood Anatomy 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 230000000146 antalgic effect Effects 0.000 abstract description 3
- 230000033228 biological regulation Effects 0.000 abstract description 3
- 210000004996 female reproductive system Anatomy 0.000 abstract description 3
- 210000001672 ovary Anatomy 0.000 abstract description 3
- 208000002193 Pain Diseases 0.000 abstract description 2
- 238000012423 maintenance Methods 0.000 abstract description 2
- 238000007670 refining Methods 0.000 abstract description 2
- 230000003750 conditioning effect Effects 0.000 abstract 1
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical compound [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 description 10
- 229910052796 boron Inorganic materials 0.000 description 10
- 239000008187 granular material Substances 0.000 description 5
- 230000036541 health Effects 0.000 description 5
- 150000001450 anions Chemical class 0.000 description 4
- 239000004816 latex Substances 0.000 description 4
- 229920000126 latex Polymers 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 239000000741 silica gel Substances 0.000 description 4
- 229910002027 silica gel Inorganic materials 0.000 description 4
- 239000002994 raw material Substances 0.000 description 3
- 210000004291 uterus Anatomy 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 2
- 230000019522 cellular metabolic process Effects 0.000 description 2
- 238000004332 deodorization Methods 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- MRELNEQAGSRDBK-UHFFFAOYSA-N lanthanum(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[La+3].[La+3] MRELNEQAGSRDBK-UHFFFAOYSA-N 0.000 description 2
- 238000002653 magnetic therapy Methods 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 108700012359 toxins Proteins 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 102000005606 Activins Human genes 0.000 description 1
- 108010059616 Activins Proteins 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- SPAGIJMPHSUYSE-UHFFFAOYSA-N Magnesium peroxide Chemical compound [Mg+2].[O-][O-] SPAGIJMPHSUYSE-UHFFFAOYSA-N 0.000 description 1
- 229910021543 Nickel dioxide Inorganic materials 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- 208000020264 Puerperal Infection Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000000488 activin Substances 0.000 description 1
- 239000002269 analeptic agent Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000008952 bacterial invasion Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000000919 ceramic Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000004927 clay Substances 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000013536 elastomeric material Substances 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 208000030172 endocrine system disease Diseases 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- MRHPUNCYMXRSMA-UHFFFAOYSA-N nickel(2+) oxygen(2-) Chemical compound [O--].[O--].[Ni++] MRHPUNCYMXRSMA-UHFFFAOYSA-N 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000005610 quantum mechanics Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/002—Magnetotherapy in combination with another treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N2/00—Magnetotherapy
- A61N2/06—Magnetotherapy using magnetic fields produced by permanent magnets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N5/0613—Apparatus adapted for a specific treatment
- A61N5/0625—Warming the body, e.g. hyperthermia treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/30—Sulfur-, selenium- or tellurium-containing compounds
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/34—Silicon-containing compounds
- C08K3/36—Silica
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/38—Boron-containing compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0658—Radiation therapy using light characterised by the wavelength of light used
- A61N2005/0659—Radiation therapy using light characterised by the wavelength of light used infrared
- A61N2005/066—Radiation therapy using light characterised by the wavelength of light used infrared far infrared
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/06—Radiation therapy using light
- A61N2005/0664—Details
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
- C08K2003/2206—Oxides; Hydroxides of metals of calcium, strontium or barium
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
- C08K2003/221—Oxides; Hydroxides of metals of rare earth metal
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
- C08K2003/2227—Oxides; Hydroxides of metals of aluminium
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
- C08K2003/2237—Oxides; Hydroxides of metals of titanium
- C08K2003/2241—Titanium dioxide
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
- C08K2003/2244—Oxides; Hydroxides of metals of zirconium
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
- C08K2003/2262—Oxides; Hydroxides of metals of manganese
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
- C08K2003/2265—Oxides; Hydroxides of metals of iron
- C08K2003/2272—Ferric oxide (Fe2O3)
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
- C08K2003/2265—Oxides; Hydroxides of metals of iron
- C08K2003/2275—Ferroso-ferric oxide (Fe3O4)
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/20—Oxides; Hydroxides
- C08K3/22—Oxides; Hydroxides of metals
- C08K2003/2296—Oxides; Hydroxides of metals of zinc
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K2201/00—Specific properties of additives
- C08K2201/01—Magnetic additives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K2201/00—Specific properties of additives
- C08K2201/014—Additives containing two or more different additives of the same subgroup in C08K
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Pathology (AREA)
- Magnetic Treatment Devices (AREA)
- Radiation-Therapy Devices (AREA)
Abstract
The invention provides the method for the consumption sub-light sub- optical wave physical therapy material of ripple composite preparation amount, comprise the following steps：(1) each component is weighed by formula, is mixed and stirred for uniformly, obtaining mixture；(2) mixture and plastic material are weighed; granulation in north glue comminutor is placed on after well mixed; the north micelle that will be made again is put into injection machine mould; mould is warmed to 170 DEG C~180 DEG C; shaped through injection in 60 100 seconds; taken out after solidification setting, then place in baking box and toasted 1.5~2.5 hours through 80 DEG C~110 DEG C, after the completion of obtain final product quantum optical wave physical therapy material through high pressure treatment of magnetizing again.The pain of the quantum optical wave physical therapy pad energy Enough fast decoupleds women physiological period Palace Inner Mo Shou Shrink, its fast decoupled refining effect can help inner membrance to come off, there is antalgic, inflammation is treated in the regulation of qi and blood, maintenance ovary, promotes uterine contractile, comprehensively effect of conditioning female reproductive system.
Description
Technical field
The present invention relates to health care technology field, in particular it relates to consumption sub-light ripple composite preparation amount sub-light ripple
The method of physiotherapy material.
Background technology
The utero-ovarian of women, is the running water source of youth glamour, and reproduction is basic, is the main right of gynemetrics's clinical research
As.Women postpartum, uterus change is maximum, thus extremely clinical concern care.Women postpartum uterus opens bleeding, causes women body
Physically weak weak, immunologic function declines, and easily by bacterial invasions such as extraneous cold-evil, is such as negligent of health care prevention, causes women postpartum body difficult
With rehabilitation, cause the complication such as puerperal infection, fall time of childbirth old old complaint, such as：The soreness of waist is suffered from abdominal pain, or chronic genitals inflammation etc., it is stupid
Gu it is and refractory.This not only influences personal psychosomatic health, also brings economic loss to family, increases mental burden.
Far infrared refers to wavelength 8-14 microns of black light, because it connects with the vibration frequency of human inner cell's molecule
Closely, after penetrating into vivo, the resonance of the atom and molecule of human body cell will be caused.By resonant absorption, rubbed between molecule
Thermosetting thermal response, promotes subcutaneous deep temperature to rise, and makes Marjoram Extract, accelerates blood circulation, therefore it is followed for blood
Various diseases that ring and microcirculation disorder cause have improvement and preventive and therapeutic effect.Anion can facilitate human body to synthesize and storage dimension life
The physiological activity of element, reinforcing and human activin, has highly important influence to human body and other biological vital movements.
Quantum is synthesized with far-infrared ray material collocation anion and magnetic.Duality principle is in quantum mechanics
Key concept.Duality principle refers to that something is provided simultaneously with the speciality of ripple and the speciality of particle.1905, Einstein proposed
Photoelectric light quantum explains that people come to realise light wave while having the double properties of ripple and particle.Nineteen twenty-four, moral
Bu Luoyi proposes " matter wave " hypothesis, and according to this hypothesis, electronics can also have the wave phenomenons such as interference and diffraction as light,
This is confirmed by later electronic diffraction experiment.
Chinese Application No. 200610035718.X patents of invention disclose a kind of far infrared deodorization and sterilization latex material,
By weight percentage, including manganese dioxide 1-3%, nickel dioxide 5-15 ‰, zirconium sesquioxide 3-6 ‰, yttria ‰,
Di-iron trioxide 2-5%, magnesium dioxide 5-15%, lanthanum sesquioxide 0.5-1%, salinization palladium 0.5-1 ‰, ceramic clay 18-27%,
Latex 70-85%.The shoe-pad made by the far-infrared powder deodorization and sterilization latex material, can kill on shoe-pad and foot it is thin
Bacterium, and its peculiar smell for producing in use is eliminated, using effect is good, but its infra red energy density is low.
The content of the invention
In order to overcome the deficiencies in the prior art, the invention provides the consumption sub-light ripple optical wave physical therapy of composite preparation amount
The method of material, the quantum optical wave physical therapy material can by far-infrared ray material and silica gel, rubber, TPR, TPU, EVA, SEBS etc.
Plastic material mixes, using mold injection, the feature quantum material for obtaining can anion releasing and far infrared light wave, have work
Inflammation is treated in blood stagnation resolvation, antalgic, the regulation of qi and blood, conserves ovary, promotes uterine contractile, and female reproductive system is nursed one's health comprehensively
Effect.
Technical scheme is as follows：The method of the consumption sub-light sub- optical wave physical therapy material of ripple composite preparation amount, institute
Stating quantum light wave composite includes following each component by weight：Aluminium dioxide (Al2O3) 3~7 parts, silica
(SiO2) 10~15 parts, zirconium sesquioxide (Zr2O3) 2~5 parts, yttria (Y2O3) 1~2 part, ferroso-ferric oxide (Fe3O4)
15~30 parts, di-iron trioxide (Fe2O3) 0.5~1 part, three oxidation dicalcium (Ca2O3) 1~5 part, Potassium oxide (K2O3) 1~2
Part, diboron trioxide (B2O3) 1~5 part, 0.16~0.3 part of manganese oxide (MnO), titanium oxide (TiO2) 15~30 parts, zinc oxide
(ZnO) 0.5~1 part, sulfur trioxide (SO3) 1~5 part, thorium oxide (ThO2) 1~5 part；
The method of the sub- optical wave physical therapy material of preparation amount is comprised the following steps：
(1) above-mentioned each component is weighed by formula, is mixed and stirred for uniformly, obtaining mixture；
(2) mixture and plastic material are weighed, it is well mixed after be placed in north glue comminutor and granulate, then will make
North micelle is put into injection machine mould, and mould is warmed to 170 DEG C~180 DEG C, is shaped through injection in 60-100 seconds, is taken after solidification setting
Go out, then place in baking box and toasted 1.5~2.5 hours through 80 DEG C~110 DEG C, after the completion of obtain final product quantum light through high pressure treatment of magnetizing again
Ripple physiotherapy material.
Used as the preferred of above-mentioned technical proposal, the plastic material is in silica gel, rubber, TPR, TPU, EVA, SEBS
Kind.
As the preferred of above-mentioned technical proposal, the quantum optical wave physical therapy pad, by weight percentage, including mixture
15%-50%, plastic material 50%-85%.
The quantum optical wave physical therapy pad for preparing in aforementioned manners.
The quantum optical wave physical therapy mattress for preparing in aforementioned manners.
The quantum optical wave physical therapy necklace for preparing in aforementioned manners.
The invention has the advantages that：Quantum optical wave physical therapy material of the present invention using silica gel, rubber, latex,
The plastic materials such as TPR, TPU, EVA, SEBS, in its internal addition sub-light wave material powder, can promote blood as main body
Liquid is circulated, and promotes cell metabolism, so as to accelerate the discharge of intracellular harmful substance, balances endocrinopathy.The quantum light wave
Physiotherapy cushion mixes quantum light wave material with plastic material, using mold injection, the feature quantum composite for obtaining, its
A lightwave network of main anion releasing and far infrared light wave and other different wave lengths and magnetic field composition is acted on, using this amount
The sub- lightwave network energy Palace Inner films of Enough fast decoupled women physiological periods receive the pain of Shrink, and its fast decoupled refining effect can help interior
Film is come off, and has antalgic, and the regulation of qi and blood is treated inflammation, conserves ovary, promotes uterine contractile, and female reproductive system is nursed one's health comprehensively
Effect of system.
The effect that quantum optical wave physical therapy pad of the present invention more fully excretes toxins in body using quantum light wave,
Preferably protection uterus is healthy, and as toxin is more smoothly discharged out, activates hemostasis, hormone in vivo balance is maintained, to maintenance
Skin, replys skin activity, and eliminating color spot on the face and whelk has greatly help.
The quantum optical wave physical therapy pad also has magnetic therapy effect simultaneously, and magnetic therapy is physical treatment, according to the magnetic that magnetic pole is produced
Property to tissue produce actively impact, to reach a kind of purpose of the treatment of non-intrusion type；Increased by adjusting human magnetic field
Cytoactive, promotes cell metabolism, activating cell, so as to accelerate intracellular waste and harmful substance to drain, balance endocrine is lost
Adjust.High-intensity magnetic field can make central nervous system stimulant lower, so as to reach analgesic effect, so having well to menalgia
Mitigation.
Brief description of the drawings：
Fig. 1 is the relative radiation power spectrum of quantum optical wave physical therapy material of the present invention.
Specific embodiment
In order that goal of the invention of the invention, technical scheme and technique effect become more apparent, with reference to specific reality
The present invention is described further to apply mode.It should be understood that specific embodiment described herein is only used for explaining the present invention, and
It is not used in the restriction present invention.
Embodiment 1
A kind of quantum light wave composite, including following each component by weight：Aluminium dioxide (Al2O3) 5 parts, two
Silica (SiO2) 15 parts, zirconium sesquioxide (Zr2O3) 4 parts, yttria (Y2O3) 2 parts, ferroso-ferric oxide (Fe3O4)25
Part, di-iron trioxide (Fe2O3) 0.5 part, three oxidation dicalcium (Ca2O3) 3 parts, Potassium oxide (K2O3) 1.5 parts, diboron trioxide
(B2O3) 3 parts, 0.3 part of manganese oxide (MnO), titanium oxide (TiO2) 30 parts, 0.5 part of zinc oxide (ZnO), sulfur trioxide (SO3) 2 parts,
Thorium oxide (ThO2) 3 parts.
With the method for the sub- optical wave physical therapy material of quantum light wave material preparation amount, comprise the following steps：
(1) raw material is weighed by the weight ratio, mixes to obtain mixture；
(2) mixture and plastic material are weighed, it is well mixed after be placed in north glue comminutor and granulate, then will make
North micelle is put into injection machine mould, and mould is warmed to 170 DEG C, is shaped through injection in 60 seconds, is taken out after solidification setting, then place roasting
Toasted 1.5 hours through 80 DEG C in case, after the completion of obtain final product quantum optical wave physical therapy material through high pressure treatment of magnetizing again.
Wherein, quantum light wave material weight degree is 30%, and plastic material weight percent content is 70%.
Embodiment 2
A kind of quantum light wave composite, including following each component by weight：Aluminium dioxide (Al2O3) 3 parts, two
Silica (SiO2) 15 parts, zirconium sesquioxide (Zr2O3) 2 parts, yttria (Y2O3) 1.5 parts, ferroso-ferric oxide (Fe3O4)15
Part, di-iron trioxide (Fe2O3) 0.5 part, three oxidation dicalcium (Ca2O3) 5 parts, Potassium oxide (K2O3) 1 part, diboron trioxide
(B2O3) 1 part, 0.16 part of manganese oxide (MnO), titanium oxide (TiO2) 15 parts, 1 part of zinc oxide (ZnO), sulfur trioxide (SO3) 1 part,
Thorium oxide (ThO2) 5 parts.
With the method for the sub- optical wave physical therapy material of quantum light wave material preparation amount, comprise the following steps：
(1) raw material is weighed by the weight ratio, mixes to obtain mixture；
(2) by the mixture and elastomeric material, granulation in north glue comminutor, then the first day of the lunar month that will be made are placed on after being well mixed
Micelle is put into injection machine mould, and mould is warmed to 180 DEG C, is shaped through injection in 100 seconds, is taken out after solidification setting, then place roasting
Toasted 2.5 hours through 110 DEG C in case, after the completion of obtain final product quantum optical wave physical therapy material through high pressure treatment of magnetizing again.
Wherein, quantum light wave material weight degree is 15%%, and plastic material weight percent content is
85%.
Embodiment 3
A kind of quantum light wave composite, including following each component by weight：Aluminium dioxide (Al2O3) 5 parts, two
Silica (SiO2) 12 parts, zirconium sesquioxide (Zr2O3) 3 parts, yttria (Y2O3) 1 part, ferroso-ferric oxide (Fe3O4)30
Part, di-iron trioxide (Fe2O3) 0.75 part, three oxidation dicalcium (Ca2O3) 1 part, Potassium oxide (K2O3) 1.5 parts, three oxidations two
Boron (B2O3) 5 parts, 0.2 part of manganese oxide (MnO), titanium oxide (TiO2) 20 parts, 0.5 part of zinc oxide (ZnO), sulfur trioxide (SO3)5
Part, thorium oxide (ThO2) 1 part.
With the method for the sub- optical wave physical therapy material of quantum light wave material preparation amount, comprise the following steps：
(1) raw material is weighed by the weight ratio, mixes to obtain mixture；
(2) mixture and TPU are weighed, granulation in north glue comminutor, then the north glue that will be made is placed on after being well mixed
Grain is put into injection machine mould, and mould is warmed to 180 DEG C, is shaped through injection in 80 seconds, is taken out after solidification setting, then place in baking box
Toasted 2 hours through 90 DEG C, after the completion of obtain final product quantum optical wave physical therapy material through high pressure treatment of magnetizing again.
Wherein, quantum light wave material weight degree is 50%%, and plastic material weight percent content is
50%.
Embodiment 4
A kind of quantum light wave composite, including following each component by weight：Aluminium dioxide (Al2O3) 7 parts, two
Silica (SiO2) 10 parts, zirconium sesquioxide (Zr2O3) 5 parts, yttria (Y2O3) 2 parts, ferroso-ferric oxide (Fe3O4)25
Part, di-iron trioxide (Fe2O3) 1 part, three oxidation dicalcium (Ca2O3) 4 parts, Potassium oxide (K2O3) 2 parts, diboron trioxide
(B2O3) 4 parts, 0.3 part of manganese oxide (MnO), titanium oxide (TiO2) 30 parts, 0.75 part of zinc oxide (ZnO), sulfur trioxide (SO3)3
Part, thorium oxide (ThO2) 3 parts.
With the method for the sub- optical wave physical therapy material of quantum light wave composite preparation amount, comprise the following steps：
(1) each component is weighed by formula, mixes to obtain mixture；
(2) mixture and plastic material are weighed, it is well mixed after be placed in north glue comminutor and granulate, then will make
North micelle is put into injection machine mould, and mould is warmed to 175 DEG C, is shaped through injection in 90 seconds, is taken out after solidification setting, then place roasting
Toasted 2.5 hours through 100 DEG C in case, after the completion of obtain final product quantum optical wave physical therapy material through high pressure treatment of magnetizing again.
The plastic material is rubber.The quantum optical wave physical therapy pad, by weight percentage, including mixture 45%,
Plastic material 65%.
Embodiment 5
A kind of quantum light wave composite, including following each component by weight：Aluminium dioxide (Al2O3) 5 parts, two
Silica (SiO2) 15 parts, zirconium sesquioxide (Zr2O3) 3 parts, yttria (Y2O3) 1 part, ferroso-ferric oxide (Fe3O4)30
Part, di-iron trioxide (Fe2O3) 0.75 part, three oxidation dicalcium (Ca2O3) 1 part, Potassium oxide (K2O3) 1.0 parts, three oxidations two
Boron (B2O3) 5 parts, 0.2 part of manganese oxide (MnO), titanium oxide (TiO2) 25 parts, 0.5 part of zinc oxide (ZnO), sulfur trioxide (SO3)5
Part, thorium oxide (ThO2) 1 part.
With the method for the sub- optical wave physical therapy material of quantum light wave composite preparation amount, comprise the following steps：
(1) each component is weighed by formula, mixes to obtain mixture；
(2) mixture and plastic material are weighed, it is well mixed after be placed in north glue comminutor and granulate, then will make
North micelle is put into injection machine mould, and mould is warmed to 180 DEG C, is shaped through injection in 100 seconds, is taken out after solidification setting, then place
Toasted 1.5 hours through 80 DEG C in baking box, after the completion of obtain final product quantum optical wave physical therapy material through high pressure treatment of magnetizing again.
Used as the preferred of above-mentioned technical proposal, the plastic material is silica gel.
As the preferred of above-mentioned technical proposal, the quantum optical wave physical therapy pad, by weight percentage, including mixture
25%, plastic material 75%.
Embodiment 6
A kind of quantum light wave composite, including following each component by weight：Aluminium dioxide (Al2O3) 7 parts, two
Silica (SiO2) 15 parts, zirconium sesquioxide (Zr2O3) 5 parts, yttria (Y2O3) 1 part, ferroso-ferric oxide (Fe3O4)25
Part, di-iron trioxide (Fe2O3) 0.75 part, three oxidation dicalcium (Ca2O3) 1 part, Potassium oxide (K2O3) 1.5 parts, three oxidations two
Boron (B2O3) 5 parts, 0.2 part of manganese oxide (MnO), titanium oxide (TiO2) 15 parts, 0.5 part of zinc oxide (ZnO), sulfur trioxide (SO3)5
Part, thorium oxide (ThO2) 1 part.
With the method for the sub- optical wave physical therapy material of quantum light wave composite preparation amount, comprise the following steps：
(1) each component is weighed by formula, mixes to obtain mixture；
(2) mixture and plastic material are weighed, it is well mixed after be placed in north glue comminutor and granulate, then will make
North micelle is put into injection machine mould, and mould is warmed to 170 DEG C, is shaped through injection in 60 seconds, is taken out after solidification setting, then place roasting
Toasted 2 hours through 90 DEG C in case, after the completion of obtain final product quantum optical wave physical therapy material through high pressure treatment of magnetizing again.
Used as the preferred of above-mentioned technical proposal, the plastic material is EVA.
As the preferred of above-mentioned technical proposal, the quantum optical wave physical therapy pad, by weight percentage, including mixture
30%, plastic material 70%.
To finished product of the present invention according to GB/T 7287-2008《Infrared radiation heater test method》Test, inspection knot
It is really：Its normal direction total emissivity is 0.88, and infra red energy density is 4.61 × 102W/m2 (37 DEG C), relative radiation power spectrum
(infrared radiation wavelength scope) is shown in Fig. 1.
Above content is to combine specific preferred embodiment further description made for the present invention, it is impossible to assert
Specific implementation of the invention is confined to these explanations.For general technical staff of the technical field of the invention,
On the premise of not departing from present inventive concept, its framework form can be flexible and changeable, can be with subseries product.Simply make some
Simple deduction or replace, should all be considered as belonging to what the claims of the present invention by being submitted to determined.
Claims (6)
1. the method for the sub- optical wave physical therapy material of consumption sub-light ripple composite preparation amount, it is characterised in that
The quantum light wave composite includes following each component by weight：Aluminium dioxide (Al2O3) 3~7 parts, dioxy
SiClx (SiO2) 10~15 parts, zirconium sesquioxide (Zr2O3) 2~5 parts, yttria (Y2O3) 1~2 part, ferroso-ferric oxide
(Fe3O4) 15~30 parts, di-iron trioxide (Fe2O3) 0.5~1 part, three oxidation dicalcium (Ca2O3) 1~5 part, Potassium oxide
(K2O3) 1~2 part, diboron trioxide (B2O3) 1~5 part, 0.16~0.3 part of manganese oxide (MnO), titanium oxide (TiO2) 15~30
Part, 0.5~1 part of zinc oxide (ZnO), sulfur trioxide (SO3) 1~5 part, thorium oxide (ThO2) 1~5 part；
The method of the sub- optical wave physical therapy material of preparation amount is comprised the following steps：
(1) above-mentioned each component is weighed by formula, is mixed and stirred for uniformly, obtaining mixture；
(2) mixture and plastic material are weighed, granulation in north glue comminutor, then the north glue that will be made is placed on after being well mixed
Grain is put into injection machine mould, and mould is warmed to 170 DEG C~180 DEG C, is shaped through injection in 60-100 seconds, is taken out after solidification setting,
Place again in baking box and toasted 1.5~2.5 hours through 80 DEG C~110 DEG C, after the completion of obtain final product quantum light wave through high pressure treatment of magnetizing again
Physiotherapy material.
2. the method for the sub- optical wave physical therapy material of preparation amount as claimed in claim 1, it is characterised in that the plastic material is silicon
One kind in glue, rubber, TPR, TPU, EVA, SEBS.
3. the method for the sub- optical wave physical therapy material of preparation amount as claimed in claim 1 or 2, it is characterised in that the quantum light wave
Physiotherapy material, by weight percentage, including the mixture 15%-50%, the plastic material 50%-85%.
4. the quantum optical wave physical therapy pad for being prepared with claim any one of 1-3 methods described.
5. the quantum optical wave physical therapy mattress for being prepared with claim any one of 1-3 methods described.
6. the quantum optical wave physical therapy necklace for being prepared with claim any one of 1-3 methods described.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710026590.9A CN106750705A (en) | 2017-01-14 | 2017-01-14 | The method of the consumption sub-light sub- optical wave physical therapy material of ripple composite preparation amount |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710026590.9A CN106750705A (en) | 2017-01-14 | 2017-01-14 | The method of the consumption sub-light sub- optical wave physical therapy material of ripple composite preparation amount |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106750705A true CN106750705A (en) | 2017-05-31 |
Family
ID=58946530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710026590.9A Pending CN106750705A (en) | 2017-01-14 | 2017-01-14 | The method of the consumption sub-light sub- optical wave physical therapy material of ripple composite preparation amount |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106750705A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108175949A (en) * | 2018-01-09 | 2018-06-19 | 山东权科生物技术有限公司 | A kind of physical therapy material and preparation method thereof |
| CN111410934A (en) * | 2020-02-24 | 2020-07-14 | 山东百花神生物科技有限公司 | Quantized composition and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101020786A (en) * | 2006-06-01 | 2007-08-22 | 张云杰 | Far infrared sterilizing and deodorizing latex material and its prepn process and sterilizing and deodorizing shoe sole |
| CN101020353A (en) * | 2006-02-14 | 2007-08-22 | 杜驈庭 | Health pad making process |
| CN105330271A (en) * | 2015-12-11 | 2016-02-17 | 东莞市洛英格纳米科技有限公司 | Preparation process of far infrared energy powder and process for manufacturing nanometer quantum wave insole through far infrared energy powder |
-
2017
- 2017-01-14 CN CN201710026590.9A patent/CN106750705A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101020353A (en) * | 2006-02-14 | 2007-08-22 | 杜驈庭 | Health pad making process |
| CN101020786A (en) * | 2006-06-01 | 2007-08-22 | 张云杰 | Far infrared sterilizing and deodorizing latex material and its prepn process and sterilizing and deodorizing shoe sole |
| CN105330271A (en) * | 2015-12-11 | 2016-02-17 | 东莞市洛英格纳米科技有限公司 | Preparation process of far infrared energy powder and process for manufacturing nanometer quantum wave insole through far infrared energy powder |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108175949A (en) * | 2018-01-09 | 2018-06-19 | 山东权科生物技术有限公司 | A kind of physical therapy material and preparation method thereof |
| CN108175949B (en) * | 2018-01-09 | 2019-09-20 | 山东权科生物技术有限公司 | A kind of physical therapy material and preparation method thereof |
| CN111410934A (en) * | 2020-02-24 | 2020-07-14 | 山东百花神生物科技有限公司 | Quantized composition and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5814078A (en) | Method and apparatus for regulating and improving the status of development and survival of living organisms | |
| CN105013087A (en) | Ingredients, a preparation method and application of an organic material comprising magnet, far-infrared and negative ion materials | |
| CN101590217B (en) | Chinese medicinal composition for treating dysthymia and preparation method thereof | |
| US20220348473A1 (en) | Terahertz material having therapeutic and health care effects, preparation method therefor and use thereof | |
| CN1032118C (en) | Method and equipment for adjusting and improving growing state of living things | |
| GB2386560A (en) | Medical Light Therapy Apparatus. | |
| CN101972517B (en) | Multi-function multi-part treating health care stone needle belt | |
| CN106750705A (en) | The method of the consumption sub-light sub- optical wave physical therapy material of ripple composite preparation amount | |
| CN106473917A (en) | Hot moxibustion particle of nano biological and preparation method thereof | |
| CN101318807A (en) | Health care physical therapy ceramic product with negative potential, far infrared, warming functions and manufacture method thereof | |
| CN105622060A (en) | Energy ceramic | |
| CN102302119A (en) | L-arabinose chewable tablet and preparation method thereof | |
| CN106260222A (en) | rose tea and preparation method thereof | |
| CN101182215A (en) | Biological chemical ceramic for medical device and preparation method thereof | |
| CN201624982U (en) | Cervical vertebra healthcare massaging pillow | |
| CN101120974A (en) | External-applied traditional Chinese medicine for treating scabies | |
| KR100378132B1 (en) | Process For Preparing Of Far Infrared ray Chip | |
| CN1207307A (en) | Bone-knitting pill and producing process thereof | |
| CN103638380B (en) | A kind of Chinese medicine preparation for the treatment of verruca plana | |
| CN103191315A (en) | Traditional Chinese medicine for treating postmenopausal osteoporosis | |
| US20230392172A1 (en) | A Bioenergy (Biophoton) Generator and its Use | |
| CN103250956A (en) | Body resistance strengthening and disease defending five-cereal nutritional powder | |
| CN108175949B (en) | A kind of physical therapy material and preparation method thereof | |
| CN100522133C (en) | Biological cosmetic cream with spot-dispelling function and its production | |
| TWI446933B (en) | Health maintenance material for use of preparing medicine for prevention and cure of cardiovascular diseases and health maintenance of biotechnology |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170531 |